Biology & biomedicineMultiplexed 'point-of-care' device for a quick simultaneous detection of biomarkers
- Details
- Category: Technological offers
-
17 Mar 2021
CSIC scientists have developed a compact device for a rapid and simultaneous detection of several biomarkers in biological fluids. The design simplifies scalability and reduces production costs, which is especially important for the obtention of ‘point-of-care’ diagnostic devices. Industrial partners from the biomedical industry are being sought to collaborate through a patent licence agreement.
IBMB-CSIC acquires a state-of-the-art electronic microscope with the most advanced electrons detector
- Details
- Category: Laboratories
-
26 Feb 2021
The microscope has been acquired by means of a cooperative project headed by CSIC, through IBMB, and has been co-financed by European FEDER funds. It is a cutting-edge technology for protein structure resolution, and it will allow facing the new biomedicine and biotechnology challenges.
SINGEK trains a new generation of Single Cell Genomics experts
- Details
- Category: Projects
-
13 Jan 2021
The SINGEK project is now finished. It was a project coordinated by the Institut de Ciències del Mar (ICM, by its Spanish acronym) of the CSIC, and it had as a main goal the training of young researchers in the application of single cell genomics for the study of microbial eukaryotes’ ecology and evolution. This emerging methodology also has applications in biotechnology and biomedicine.
A more effective nanomedicine has been developed for the treatment of Fabry rare disease
- Details
- Category: Success stories
-
26 Feb 2021
This is one of the major achievements of the European Smart4Fabry project, which is now coming to an end after four years of work. The results have been made possible by nanotechnology and the approach developed could be applied to other drugs in the future. The new drug improves on current treatments and helps reduce costs and improve patients' quality of life.
A laboratory at the IQAC-CSIC obtains the biosafety level 2 accreditation
- Details
- Category: Laboratories
-
29 Dec 2020
The Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) has obtained the biosafety level 2 accreditation for one of its laboratories, which allows the laboratory to work with biological agents classified in the risk group 2.
